Decriminalization Campaigners

Grassroots Massachusetts advocacy organization that combines public education, harm reduction framing, and municipal policy campaigns to decriminalize and expand responsible access to entheogenic plants and fungi.

DecriminalizeSF is a grassroots organization in San Francisco, California that advocates for the decriminalization of natural psychedelics, such as psilocybin and ayahuasca, and plant medicines. The organization works to raise awareness about the therapeutic potential of these substances and to bui…

California grassroots ballot initiative campaign advocating decriminalization and legal access reform for psilocybin and psilocybin-containing mushrooms, with expungement language in campaign materials.

Decriminalize Nature is a U.S.-based grassroots network that works through national support and local chapters in cities, states, and some international locations listed on its site, including chapters in places such as California, Michigan, Minnesota, France, and Canada. Its core activities include community organizing, public education, local campaign building, and encouraging local governments to change policy around entheogenic plants and fungi. The organization says its local chapters are the primary vehicle for change and that chapters build awareness, educate the public, and propose legislation. In psychedelic policy, Decriminalize Nature focuses on decriminalization and expanded access for entheogenic plants and fungi, with a stated emphasis on direct political action and local change rather than expensive ballot-driven approaches. Its site describes a five-point plan aimed at incorporating reverence, social equity, and community-serving markets into policy discussions, and its organizer materials support local campaigns and legislation efforts. Potential collaboration areas include local policy work, public education, research-informed advocacy, and coalition building with clinicians, funders, patient communities, and reform groups that want to support access-focused civic campaigns.

Washington, DC campaign coalition that organized Initiative 81 and continues public education and policy work around decriminalization of entheogenic plants and fungi.

Local Wisconsin grassroots campaign advocating safe and responsible decriminalization of entheogenic plants and fungi in Madison.

Philadelphia-based grassroots policy advocacy organization focused on local decriminalization of natural entheogens and related public-health policy education.

Drug Policy Alliance is a U.S.-based nonprofit policy advocacy organization headquartered in New York City, with state offices in California, New York, and Washington, D.C. It works nationally on drug policy reform through policy solutions, organizing, public education, and advocacy focused on evidence, health, equity, and human rights. Its public-facing work centers on ending punitive drug policy and replacing it with regulated, health-oriented approaches. In psychedelics, DPA is an adjacent drug-policy stakeholder rather than a psychedelic-only organization. It has published documented educational material on psilocybin that frames psychedelics as promising therapeutic tools, discusses harm reduction, and notes the current federal illegality of psilocybin in most cases. Current campaigns also include decriminalization, marijuana criminalization reform, and broader public-health approaches to drug regulation, which makes DPA a relevant collaborator for researchers, clinicians, funders, and patient communities working on access, evidence translation, and equitable policy change.

Healing Advocacy Fund is a U.S.-based 501(c)(3) nonprofit focused on state-regulated psychedelic therapy access, with its clearest documented work in Oregon and Colorado and emerging references to New Mexico. It says it was formed after Oregon voters passed Measure 109 to help ensure the state’s psilocybin program was implemented as intended. Its public-facing materials describe it as supporting safe, affordable access to psychedelic healing for people who need it. The organization’s work centers on policy implementation, patient access, and public education around regulated psilocybin services. Documented activities include advocacy for Oregon program improvements, support for Colorado’s rollout under Proposition 122, educational resources for patients and clinicians, and an adverse-event reporting system in Oregon. Its field role appears to be a campaign and implementation-support organization that connects policy design, healthcare integration, and access expansion for regulated psychedelic therapy.

Norwegian network conducting public education and policy engagement to change laws and social attitudes around psychedelics and MDMA across recreational, ceremonial, and therapeutic contexts.

Release is a UK drugs law and legal reform organization based in London and operating nationally across England and Wales through advice, legal support, outreach, and policy work. Its public-facing services include a national helpline, legal advice, drug advocacy, and community legal welfare outreach delivered in drug treatment centers, homelessness projects, and sexual health clinics across 21 locations. It says its core audience includes people with a history of drug use, people affected by drug laws, and professionals seeking advice on drug law and harm reduction. Release’s advocacy role is centered on evidence-based drug policy, public health, human rights, and decriminalization, with published research on racial disparities in drug enforcement and comparative decriminalization models. Its current public work includes the “Gear Has Changed” public health campaign on drug supply contamination and ongoing responses to government and international consultations on drug laws and enforcement. It is adjacent to psychedelic policy rather than psychedelic-specific, but its drug law, harm reduction, and controlled-substance expertise may be relevant to researchers, clinicians, funders, policy groups, and patient communities working on regulated access and reform.

Students for Sensible Drug Policy is a global youth-led network focused on drug policy reform, with chapters and affiliates in the United States and other countries. It organizes students, young professionals, and emerging advocates through campus chapters, community chapters, and ambassador activities. Its core work includes policy advocacy, public education, and local organizing around drug laws and campus policies. SSDP is explicitly engaged in psychedelic policy reform as part of its broader drug policy agenda. Current documented efforts include its Psychedelic Policy Reform work, the Psychedelic Pipeline for career development and mentorship, and sponsorship of the North Carolina Psychedelic Policy Coalition. The group also works on blocking restrictions on psychedelic research chemicals and on broader reform areas such as harm reduction, decriminalization, and student-facing drug education.

Transform Drug Policy Foundation is a UK-based independent charity that works nationally and internationally on drug policy reform. Its main audience includes policymakers, the public, governments, and practitioners, and its core work is public education, policy analysis, and promoting legal regulation models for currently illegal drugs. In psychedelic policy, Transform is clearly active and has published guidance on how to regulate psychedelics, with a focus on non-medical adult use and broader legal frameworks. Its work also emphasizes equity, Indigenous rights, corporate capture mitigation, and international treaty questions, making it relevant to policy groups, researchers, funders, and community stakeholders interested in regulated access and drug law reform.